Press "Enter" to skip to content

Alembic Pharma gets USFDA nod for seizure treatment drug

The approved product is therapeutically equivalent to the reference listed drug Klonopin orally disintegrating tablets of Hoffmann-La Roche, Inc.

Original source: https://health.economictimes.indiatimes.com/news/pharma/alembic-pharma-gets-usfda-nod-for-seizure-treatment-drug/70021637?utm_source=RSS&utm_medium=ETRSS

Also Read:   US admits multiple molecular formulations effective in cardiovascular diseases: Industry